John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Ceragon Networks
CRNT
$189M
| $1.52M | ﹤0.01% |
648,019
+351,431
| +118% | +$1.29M |
|
1852
AdvanSix
ASIX
$442M
| $1.52M | ﹤0.01% |
67,196
+52,122
| +346% | +$1.45M |
|
1853
RLJ Lodging Trust
RLJ
$1.76B
| $1.52M | ﹤0.01% |
192,444
-295,959
| -61% | -$2.78M |
|
1854
World Acceptance Corp
WRLD
$902M
| $1.52M | ﹤0.01% |
11,972
+1,258
| +12% | +$164K |
|
|
ESGR
1855
DELISTED
Enstar Group
ESGR
| $1.51M | ﹤0.01% |
4,557
+1,953
| +75% | +$644K |
|
1856
Masco
MAS
$14.4B
| $1.51M | ﹤0.01% |
21,775
+8,747
| +67% | +$655K |
|
1857
Gold Fields
GFI
$43.7B
| $1.51M | ﹤0.01% |
68,291
+4,035
| +6% | +$73.8K |
|
1858
Elbit Systems
ESLT
$33.8B
| $1.5M | ﹤0.01% |
3,922
+67
| +2% | +$21.7K |
|
1859
Tarsus Pharmaceuticals
TARS
$3.14B
| $1.5M | ﹤0.01% |
29,282
-61,889
| -68% | -$3.06M |
|
1860
Nutrien
NTR
$34.8B
| $1.5M | ﹤0.01% |
30,200
-271,305
| -90% | -$13.9M |
|
1861
4D Molecular Therapeutics
FDMT
$868M
| $1.49M | ﹤0.01% |
461,457
+147,464
| +47% | +$695K |
|
1862
Veralto
VLTO
$24.1B
| $1.49M | ﹤0.01% |
15,279
+147
| +1% | +$14.7K |
|
1863
Globalstar
GSAT
$10.6B
| $1.49M | ﹤0.01% |
71,353
-43,516
| -38% | -$1.05M |
|
1864
NewtekOne
NEWT
$360M
| $1.49M | ﹤0.01% |
124,447
+34,040
| +38% | +$430K |
|
1865
Avantis US Small Cap Value ETF
AVUV
$31.2B
| $1.48M | ﹤0.01% |
17,000
+13,600
| +400% | +$1.28M |
|
1866
CALL
VanEck Semiconductor ETF
SMH
$65.9B
| $1.48M | ﹤0.01% |
+7,000
| New | +$1.68M |
|
|
1867
PUT
VanEck Semiconductor ETF
SMH
$65.9B
| $1.48M | ﹤0.01% |
+7,000
| New | +$1.68M |
|
1868
SM Energy
SM
$8.49B
| $1.48M | ﹤0.01% |
49,392
-16,991
| -26% | -$609K |
|
1869
Banner Corp
BANR
$2.39B
| $1.48M | ﹤0.01% |
23,187
-3,433
| -13% | -$231K |
|
1870
BBB Foods
TBBB
$6.14B
| $1.47M | ﹤0.01% |
55,168
-2,858
| -5% | -$79.6K |
|
1871
iShares Morningstar Small-Cap Value ETF
ISCV
$704M
| $1.47M | ﹤0.01% |
+24,800
| New | +$1.56M |
|
1872
Senseonics Holdings Inc
SENS
$503M
| $1.47M | ﹤0.01% |
112,042
+108,614
| +3,168% | +$1.79M |
|
1873
KeyCorp
KEY
$23.4B
| $1.47M | ﹤0.01% |
91,763
-17,348
| -16% | -$294K |
|
|
NXDR
1874
Nextdoor Holdings
NXDR
$925M
| $1.47M | ﹤0.01% |
958,787
-181,197
| -16% | -$405K |
|
1875
Walmart Inc
WMT
$839B
| $1.46M | ﹤0.01% |
16,666
-29,734
| -64% | -$2.79M |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.